MOG-IgG3 may thus well be involved in the immunopathogenesis of MOG-EM/MOGAD in addition to MOG-IgG1, and MOG-IgG3 seropositivity in patients with MOG-EM/MOGAD might therefore also have therapeutic implications. Here, IGHG3 is linked to erythema multiforme.